GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India · Delayed Price · Currency is INR 3,050.10
-56.30 (-1.81%)
Aug 31, 2026, 3:29 PM IST
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 517.21 billion as of August 31, 2026. Its market cap has increased by 9.69% in one year.
Market Cap
517.21B
Enterprise Value
489.98B
Revenue
39.55B
Ranking
n/a
PE Ratio
48.42
Stock Price
3,050.10
ChartMarket Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 517.21B, an increase of 2,602.25%. That is a compound annual growth rate of 14.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 517.21B | 23.56% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.61T |
| Divi's Laboratories | 2.45T |
| Apollo Hospitals Enterprise | 1.27T |
| Zydus Lifesciences | 1.19T |
| Biocon | 665.78B |
| Alkem Laboratories | 640.27B |
| Anthem Biosciences | 506.93B |
| Ipca Laboratories | 494.80B |